Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and Bavarian Nordic A/S (OTCMKTS:BVNRY – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, dividends, earnings, valuation, profitability, risk and institutional ownership. Profitability This table compares Taysha […]
Canaccord Genuity Group reaffirmed their buy rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report published on Thursday morning, Benzinga reports. Canaccord Genuity Group currently has a $7.00 price objective on the stock. TSHA has been the topic of a number of other research reports. Cantor Fitzgerald reissued an overweight […]
Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its price objective boosted by Chardan Capital from $5.00 to $7.00 in a research note published on Thursday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other research firms have also weighed in on TSHA. JMP Securities reissued a market […]
Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its price target boosted by Needham & Company LLC from $5.00 to $7.00 in a research report report published on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. Separately, Cantor Fitzgerald reaffirmed an overweight rating and issued a $7.00 price target on […]
Cantor Fitzgerald restated their overweight rating on shares of Taysha Gene Therapies (NASDAQ:TSHA – Free Report) in a report released on Wednesday morning, Benzinga reports. Cantor Fitzgerald currently has a $7.00 target price on the stock. Separately, Needham & Company LLC lifted their target price on shares of Taysha Gene Therapies from $5.00 to $7.00 […]